November 8, 2016 6:22am
… No matter who wins, investors are screwed …
The reality will be some resolution of uncertainty
… Investors are still dealing with a cavalier attitude toward development and platform risks
I answer one question; in which company should investors put, keep and commit their money!
If you are not a subscriber, you won’t know the morning’s indications and who is in the headlights.
I write in every line that investors need to avoid risks as if I were the first to be hurt if I am wrong!
RegMed Investors’ (RMi) provides exclusive and original content; put your eyes on the page to figure out what’s really going on!
Indexes and ETFs: The IBB (+3.69%) is UP, IWM (-0.18%) is DOWN and the XBI and XLV are NOT indicating
Dow futures are DOWN -0.09% and NASDAQ futures are DOWN -0.16%
U.S. stock index futures indicated a flat open with investors focused firmly on the elections as voters head to the ballot box on Tuesday.
European stocks opened mixed as investors remain cautious over the U.S. election results.
Asian markets eked out modest gains after oscillating between positive and negative territory, as the world's most closely watched election drew near.
Data docket: the Job Openings and Labor Turnover Summary (JOLTS) is due at 10.00 a.m. ET and a survey from the National Federation of Independent Business (NFIB) is due before that at 6.00 a.m. ET.
The stem, cell, gene and regenerative therapy (SCG&RT) sector closed POSITIVE on Monday and Friday, NEGATIVE on Thursday, Wednesday and POSITIVE last Tuesday.
The SCG&RT sector’s record after the last 5 days (of 43 covered companies):
· Monday closed POSITIVE with 13 decliners, 25 advancers and 5 flat;
· Friday closed POSITIVE on Friday with 8 decliners, 31 advancers and 4 flats;
· Thursday closed NEGATIVE with 37 decliners, 5 advancers and 1 flat;
· Wednesday closed NEGATIVE with 36 decliners, 6 advancers and 1 flat;
· Last Tuesday closed POSITIVE with 14 decliners, 26 advances and 3 flats;
Remembering Monday’s closing post, “sector kicks off the week on an UP note … Could this be considered a political/market demonstration …? Not quite a ticker tape. I believe after all the cheering or crying, the market and sector will SELL-OFF.”
- Following all of Monday's “hoop-la” and showy demonstrations; investors seem ready for it to be over … as well as cautious on Tuesday as U.S. voters prepare to head to the voting booth to choose their next president.
But as unpredictable as this election run has been; stocks have been fairly predictable after the election, tending to sell off.
The view from the box seats: U.S. equities have risen only about one out of every three times <after elections>since 1928, according to Bespoke data, tracking S&P 500 index SPX, +2.22% returns on the days after a U.S. presidential election. Dow Jones’s says “the average change on the day after Election Day is 0.9%, with the top 5 declines arriving in the wake victories by Democratic presidents.”
- I voted early but, turnout today should be huge as polarized voters get to make a choice but, which one? It is in the wind!
Investors are due … a reprieve from all the election rocks, boulders, spears and sand being thrown. Markets are nervous and both candidates promise respite – don’t bet on it …
.
You’ve made it to the office, turned on the monitor, having just gotten your coffee and it hits you - what could be today’s trades?
Watch list:
· The iShares Nasdaq Biotechnology (IBB) closed Monday up +3.76% and is UP +3.69% in Tuesday’s pre-market;
· The SPDR S&P Biotech ETF (XBI) closed Monday up +4.50% and is NOT indicating in Tuesday pre-market;
· The Health Care Select Sector SPDR ETF (XLV) closed up +2.56% Monday and is NOT indicating in Tuesday’s pre-market;
· The iShares Russell 2000 (IWM) closed up +2.45% on Monday and is DOWN -0.18% in Tuesday’s pre-market.
Companies in my headlights:
On the whole, I abstain from individual prognostication – again, guesses don’t matter – facts speak.
The bloom will come off many recent roses!
However, I still believe some sector equities are OVERBOUGHT. As quarterly reporting season gets going … I will re-shuffle the deck … after we hear more from company’s releases …
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
Henry’s comments are for informational purposes only and are not a substitute for personalized advice. Consult your advisor about what is best for you.
